Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company News
Is This Biotech's Best Stock?
Fool about 14 hours agoHave J&J's Approval Hopes Vanished?
Fool about 2 days agoJohnson & Johnson might have trouble sidestepping the competition.
Amylin Shares Jump as Sanofi, Merck Sumbit Bids
Benzinga about 2 days agoHigh Profitability and Low Valuation for Gilead
Fool about 2 days agoHigh Profitability and Low Valuation for Gilead
Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
Street Insider about 2 days agoBarclays Remains Bullish on Vertex (VRTX); Upside to Phase I Data
Street Insider about 2 days agoAre 3 Failed Phase 3 Trials Enough?
Fool about 4 days agoThe NExUS between ESCAPE and MISSION is failure.
Is Bristol a Buy Post-Plavix
Fool about 4 days agoWhy Idenix is a Good Bet for Aggressive Investors
Fool about 4 days agoWhy Idenix is a Good Bet for Aggressive Investors
Too Little, Too Late for Achillion?
Fool about 5 days agoAchillion produces solid hepatitis C data, but competitors are out in front.
How to Play an Arena Delay
Fool about 5 days agoThis options strategy could be profitable if the FDA delays its decision.
Bristol-Myers Squibb's Thud Heard Round the World
Fool about 7 days agoBristol-Myers' dark ages have arrived as Plavix comes off patent.
China Biotech Week In Review: J&J Actively Pursuing M&A In China
about 8 days agoYou may also be interested in these BMY related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BMY | 33.09 | +0.10 | +0.30% | 55.84B |
| BMTI | 2.43 | +0.02 | +0.83% | 68.36M |
| BMRN | 38.64 | +0.13 | +0.34% | 4.468B |
| BMJ | 0.93 | +0.00 | +0.00% | |
| BMI | 36.69 | -0.25 | -0.68% | 550.35M |
| BMC | 43.69 | +0.72 | +1.68% | 7.175B |
| BMA | 13.46 | -0.33 | -2.39% | 785.12M |
| BLX | 19.14 | -0.08 | -0.42% | 540.90M |
| BLV | 93.83 | +0.41 | +0.44% | |
| BLTI | 2.42 | +0.06 | +2.54% | 74.27M |
